IP Library Granted Patent US 10,899,715
Granted Patent B2
US 10,899,715 · App. 16/378,868 · Granted Jan 26, 2021

Continuous flow carboxylation reaction

Inventors: Scott Tweedie (Albany, NY); Sripathy Venkatraman (Albany, NY); James Zeller (Scottsdale, AZ)
Assignee: NOVARTIS AG
C07D217/04B01J19/24B01J19/242B01J19/243B01J2219/00099B01J2219/0286B01J2219/24
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,899,715
App. No.
16/378,868
Granted
Jan 26, 2021
Kind
B2
Abstract

The present invention is related to a two-step carboxylation reaction of an aryl group using continuous flow reaction conditions. This process permits large scale synthesis of useful reaction products in high yield.

Claims (15)

1. A process of preparing a compound of Formula I:

comprising:

reacting a compound of Formula II:

with n-BuLi and tetramethylethylenediamine at −78° C. to afford a compound of Formula III:

quenching said compound of Formula III with gaseous carbon dioxide to afford a compound of Formula IV:

and

treating said compound of Formula IV with HCl to afford the compound of Formula I, wherein said method is performed using continuous flow reaction conditions, and wherein a reaction temperature is maintained at less than −65° C. during the quenching with gaseous carbon dioxide.

2. The process of claim 1 , wherein said reacting a compound of Formula II with n-BuLi and tetramethylethylenediamine at −78° C. is performed in a polar aprotic solvent.

3. The process of claim 2 , wherein said polar aprotic solvent is THF.

4. The process of claim 1 , wherein said reacting a compound of Formula IV with HCl is performed in a polar solvent.

5. The process of claim 4 , wherein said polar solvent is 1,4-dioxane.

6. The process of claim 1 , wherein said HCl is 4N HCl.

7. The process of claim 1 , wherein the compound of Formula I is an intermediate used in the synthesis of lifitegrast.

8. The process of claim 1 , wherein said process is carried out in a continuous flow batch reactor.

9. The process of claim 8 , wherein said continuous flow batch reactor comprises stainless steel reactor tubes.

Assignments (8)
INTELLECTUAL PROPERTY SECURITY AGREEMENT Recorded Dec 23, 2025
From: BAUSCH + LOMB IRELAND LIMITED
To: JPMORGAN CHASE BANK, N.A., AS COLLATERAL AGENT
Reel/Frame 074050/0573 →
INTELLECTUAL PROPERTY SECURITY AGREEMENT Recorded Dec 23, 2025
From: BAUSCH + LOMB IRELAND LIMITED
To: CITIBANK, N.A., AS NOTES COLLATERAL AGENT
Reel/Frame 074050/0709 →
INTELLECTUAL PROPERTY SECURITY AGREEMENT Recorded Dec 23, 2025
From: BAUSCH + LOMB IRELAND LIMITED
To: CITIBANK, N.A., AS NOTES COLLATERAL AGENT
Reel/Frame 074050/0682 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 6, 2023
From: NOVARTIS AG
To: BAUSCH + LOMB IRELAND LIMITED
Reel/Frame 065790/0208 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 31, 2019
From: SARCODE BIOSCIENCE INC.
To: NOVARTIS AG
Reel/Frame 050900/0268 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 15, 2019
From: ALBANY MOLECULAR RESEARCH, INC.
To: SARCODE BIOSCIENCE INC.
Reel/Frame 048901/0980 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 15, 2019
From: TWEEDIE, SCOTT; VENKATRAMAN, SRIPATHY
To: ALBANY MOLECULAR RESEARCH, INC.
Reel/Frame 048901/0823 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 15, 2019
From: ZELLER, JAMES
To: SARCODE BIOSCIENCE INC.
Reel/Frame 048887/0718 →